iShares Biotechnology ETF Rating $170.00 +0.06 (+0.04%) As of 04:00 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsSEC FilingsShort InterestTrendsBuy This Stock iShares Biotechnology ETF Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.IBB Aggregate RatingModerate Buy 2.74Holdings in IBB have an aggregate rating of Moderate Buy based on 524 analyst ratings issued in the past year covering 25 companies (65.6% of the portfolio).IBB Aggregate Price Target$170.00High Prediction$170.00Average Prediction$170.00Low Prediction$170.00Holdings in IBB have an aggregate price target of $170.00 and a range of $170.00 to $170.00 covering 25 companies (65.6% of the portfolio).IBB Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy2 Buy rating(s)Moderate Buy18 Moderate Buy rating(s)Hold4 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by iShares Biotechnology ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 25 IBB Holdings ExportWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings7.46%GILDGilead Sciences$133.52+1.7%4.6935 of 5 stars2.86$157.04 17.6%28Trending NewsEarnings ReportDividend AnnouncementAnalyst Forecast7.20%VRTXVertex Pharmaceuticals$435.17+1.2%4.5349 of 5 stars2.85$555.17 27.6%26Earnings ReportAnalyst UpgradeAnalyst Revision7.17%AMGNAmgen$329.59-0.6%4.0292 of 5 stars2.48$357.12 8.4%31Analyst Revision6.67%REGNRegeneron Pharmaceuticals$712.77-0.3%4.429 of 5 stars2.77$826.59 16.0%26Positive News3.64%ALNYAlnylam Pharmaceuticals$284.84-3.5%4.4242 of 5 stars2.81$471.96 65.7%26Analyst Revision3.35%ARGXargenex$813.28+4.0%4.7262 of 5 stars2.92$1,017.78 25.1%24Earnings ReportAnalyst ForecastAnalyst Revision2.65%INSMInsmed$103.89+2.5%3.3978 of 5 stars3.00$211.86 103.9%25Earnings ReportAnalyst ForecastHigh Trading Volume2.56%BIIBBiogen$197.95+2.3%3.7502 of 5 stars2.50$214.23 8.2%28Analyst Revision2.55%NTRANatera$199.14+2.5%3.6894 of 5 stars2.79$255.33 28.2%19Analyst Forecast2.26%UTHRUnited Therapeutics$569.88+0.9%3.5527 of 5 stars2.85$619.42 8.7%13Earnings ReportInsider Trade2.24%RVMDRevolution Medicines$144.15+1.7%2.2873 of 5 stars3.10$103.88 -27.9%20Earnings ReportAnalyst Revision1.95%ONCBeOne Medicines$310.75-0.4%4.3707 of 5 stars2.79$391.00 25.8%14Analyst Upgrade1.88%ILMNIllumina$142.51+0.4%3.1292 of 5 stars2.22$131.06 -8.0%18Analyst Downgrade1.78%INCYIncyte$100.32+1.8%4.491 of 5 stars2.43$104.26 3.9%211.53%MRNAModerna$52.88-2.7%1.5012 of 5 stars1.84$35.73 -32.4%19Trending NewsGap UpHigh Trading Volume1.27%ROIVRoivant Sciences$28.96+1.4%2.5981 of 5 stars2.75$30.55 5.5%12Positive NewsAnalyst ForecastGap Up1.20%NBIXNeurocrine Biosciences$150.59-1.1%3.1648 of 5 stars2.82$184.15 22.3%22Analyst Forecast1.18%GMABGenmab A/S$26.18-0.9%4.426 of 5 stars2.83$39.07 49.2%12Earnings ReportAnalyst Downgrade1.14%IONSIonis Pharmaceuticals$75.38-0.4%3.5621 of 5 stars2.86$99.35 31.8%211.06%BBIOBridgeBio Pharma$64.68-4.0%3.4501 of 5 stars2.92$88.19 36.3%25Trending NewsEarnings ReportAnalyst ForecastInsider TradeGap Up1.02%EXELExelixis$49.71+3.2%3.1642 of 5 stars2.39$47.83 -3.8%23Earnings ReportAnalyst UpgradeInsider Trade1.00%MDGLMadrigal Pharmaceuticals$497.03-2.6%3.081 of 5 stars2.76$682.07 37.2%17Earnings ReportAnalyst Revision0.96%BMRNBioMarin Pharmaceutical$52.58-2.7%4.5237 of 5 stars2.74$89.91 71.0%23Analyst ForecastInsider Trade0.94%ASNDAscendis Pharma A/S$238.67+0.0%4.6058 of 5 stars2.95$291.50 22.1%19Positive NewsEarnings ReportAnalyst Forecast0.91%ARWRArrowhead Pharmaceuticals$77.74+6.9%2.0801 of 5 stars2.83$84.90 9.2%12Earnings ReportAnalyst Forecast This page (NASDAQ:IBB) was last updated on 5/11/2026 by MarketBeat.com Staff. From Our PartnersSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | Sponsored$30 stock to buy before Starlink goes public (WATCH NOW!)A little-known stock pick with money-doubling potential over the next year is revealed for free in the first t...Paradigm Press | SponsoredIran's New Leader Just Said Something That Should Terrify Every AmericanIran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...American Alternative | SponsoredYour book attachedYour Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...Profits Run | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredTrade this between 9:30 and 10:45 am ESTThe first 75 minutes of the trading day may be the most overlooked window for consistent opportunities.If you ...Base Camp Trading | SponsoredIran War Shock: What I Was Told In That Private MeetingYou’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...Banyan Hill Publishing | SponsoredElon’s AI supercomputer just went live. Here’s my #1 stock.Is Elon about to trigger another 315X opportunity? Elon gave Tesla investors the chance to make more than 3...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iShares Biotechnology ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share iShares Biotechnology ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
